Stuart Wood is a commercially oriented leader in pricing, market access, and health economics outcomes research, with a robust background in the public policy industry and biotechnology sector. They hold a Master’s Degree focused on economic evaluation in healthcare from City University London and have extensive experience in market access and health technology assessment at both national and global levels. Currently, Stuart serves as the Senior Director of International Market Access at Rhythm Pharmaceuticals Inc. and as Company Secretary at 955 Consulting Ltd. They have previously held significant roles at Pharming Group N.V., Aimmune Therapeutics, and Ipsen, among others.
This person is not in any teams
This person is not in any offices